메뉴 건너뛰기
Inflammatory Bowel Diseases
Volumn 13, Issue 11, 2007, Pages 1453-1454
Fulminant hepatic failure in chronic hepatitis B on withdrawal of corticosteroids, azathioprine and infliximab for Crohn's disease [4]
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; INFLIXIMAB; LAMIVUDINE; PREDNISONE;
EID: 36749054694     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20216     Document Type: Letter
Times cited : (53)
References (8)
  • 1
    • 33748641944 scopus 로고    scopus 로고
    • Systematic review: Lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection
    • Kohrt HE, Ouyang DL, Keefe ED. Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther. 2006;24:1003-1016.
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 1003-1016
    • Kohrt, H.E.1    Ouyang, D.L.2    Keefe, E.D.3
  • 2
    • 33644545429 scopus 로고    scopus 로고
    • Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
    • Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43:209-220.
    • (2006) Hepatology , vol.43 , pp. 209-220
    • Yeo, W.1    Johnson, P.J.2
  • 3
    • 33748173669 scopus 로고    scopus 로고
    • Hepatitis B reactivation after cytotoxic chemotherapy: The disease and its prevention
    • Mindikoglu AL, Regev A, Schiff ER. Hepatitis B reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastro Hepatol. 2006;4:1076-1081.
    • (2006) Clin Gastro Hepatol , vol.4 , pp. 1076-1081
    • Mindikoglu, A.L.1    Regev, A.2    Schiff, E.R.3
  • 4
    • 84984575715 scopus 로고    scopus 로고
    • Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
    • Cheng AL, Hsiung CA, Su IJ, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology. 2003;37:1320-1328.
    • (2003) Hepatology , vol.37 , pp. 1320-1328
    • Cheng, A.L.1    Hsiung, C.A.2    Su, I.J.3
  • 5
    • 4344614501 scopus 로고    scopus 로고
    • Chronic hepatitis B reactivation following infliximab therapy in Crohn 's disease patients: Need for primary prophylaxis
    • Esteve M, Saro C, Gonzalez-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn 's disease patients: need for primary prophylaxis. Gut. 2004;53:1363-1365.
    • (2004) Gut , vol.53 , pp. 1363-1365
    • Esteve, M.1    Saro, C.2    Gonzalez-Huix, F.3
  • 6
    • 4644254334 scopus 로고    scopus 로고
    • Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection
    • Garcia-Sanchez M, Gomez-Camacho F, Poyato-Gonzalez A, et al. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection. Inflamm Bowel Dis. 2004;10:701-702.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 701-702
    • Garcia-Sanchez, M.1    Gomez-Camacho, F.2    Poyato-Gonzalez, A.3
  • 7
    • 33645094377 scopus 로고    scopus 로고
    • Subfulminant hepatitis B after infliximab in Crohn's disease: Need for HBV-screening?
    • Millonig G, Kern M, Ludwiczek, et al. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?. World J Gastroenterol 2006:4:974-976.
    • (2006) World J Gastroenterol , vol.4 , pp. 974-976
    • Millonig, G.1    Kern, M.2    Ludwiczek3
  • 8
    • 34247592817 scopus 로고    scopus 로고
    • Occult hepatitis B and infliximab-induced HBV reactivation
    • Madonia S, Orlando A, Scimeca D, et al. Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis. 2007;13:508-509.
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 508-509
    • Madonia, S.1    Orlando, A.2    Scimeca, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.